Celularity Announces Multiple Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2021 – GlobeNewswire
stemadminStem Cell ResearchNo comments

FLORHAM PARK, N.J., April 09, 2021 (GLOBE NEWSWIRE) -- Celularity Inc. (Celularity), a clinical-stage biotechnology company, leading the next evolution in cellular medicine with the development of off-the-shelf allogeneic therapies derived from the postpartum human placenta, will display multiple presentations at the American Association for Cancer Research (AACR) Annual Meeting 2021. The presentations include one poster highlighting early clinical data of CYNK-001 (unmodified natural killer (NK) cell therapy) in COVID-19, and the other showcasing integration of immune monitoring assays with measurement of minimal residual disease for hematological disease translational studies.

Read more
Human blastocyst-like structures generated entirely from pluripotent stem cells. Shifting the paradigm of developmental biology? – ESHRE
stemadminStem Cell ResearchNo comments

Four research groups have in the past few weeks independently reported that they have grown clusters of cells which mimic the function of human blastocysts. Susana Chuva de Sousa Lopes, co-ordinator of ESHREs SIG Stem Cells, and deputy Mina Popovic describe how these breakthroughs might extend the present limits on human embryo research. Until now knowledge of early mammalian development has relied heavily on observing and manipulating human and animal embryos directly

Read more
Comprehensive Report on Stem Cell Therapy Market 2021 | Size, Growth, Demand, Opportunities & Forecast To 2026 | Cellular Dynamics…
stemadminStem Cell ResearchNo comments

The report presents an in-depth assessment of GlobalStem Cell Therapyincluding key market drivers, challenges, investment potential, vertical market opportunities and use cases, future roadmap, value chain, case studies on Stem Cell Therapy, vendor profiles, market share and strategies. Global Stem Cell Therapy Market: Manufacturers Segment Analysis (Company and Product introduction, Sales Volume, Revenue, Price and Gross Margin):. Request for Sample Report @https://www.industryandresearch.com/report/GlobalChina-Stem-Cell-Therapy-Market-Report-Insight-Key-Research-Findings-Competative-Landscape-and-Future-Forecast-20202026/235381#samplereport These research report also provides an overall analysis of the market share, size, segmentation, revenue forecasts and geographic regions of the Stem Cell Therapy Market along with industry leading players are studied with respect to their company profile, product portfolio, capacity, price, cost and revenue

Read more
New approach to CAR T gene therapy yields efficient and longer-lasting response against HIV – News-Medical.Net
stemadminStem Cell ResearchNo comments

Findings A UCLA research team has shown that using a truncated form of the CD4 molecule as part of a gene therapy to combat HIV yielded superior and longer-lasting results in mouse models than previous similar therapies using the CD4 molecule. This new approach to CAR T gene therapy -- a type of immunotherapy that involves genetically engineering the body's own blood-forming stem cells to create HIV-fighting T cells -- has the potential to not only destroy HIV-infected cells but to create "memory cells" that could provide lifelong protection from infection with the virus that causes AIDS. CAR therapies have emerged as a powerful immunotherapy for various forms of cancer and show promise for treating HIV-1, the more prevalent of the two main forms of the virus.

Read more
The entelechy test: embryos and simbryos – BioNews
stemadminStem Cell ResearchNo comments

29 March 2021 Over two weeks in March, four teams reported the self-assembly from stem cells of structures resembling human embryos. Following two preprints reporting similar results, Nature published peer-reviewed papers confirming that humanblastocyst-like structures (dubbed 'blastoids') could assemble themselves fromhuman pluripotent stem cells (hPSCs) or induced pluripotent stem (iPS) cells. The use of such 'blastoids' could avoid the ethically-problematic demand for, and limited supply of, human eggs and embryos, enabling more researchers to study the underpinnings of infertility and congenital disease in greater detail

Read more
Global Regenerative Medicine Conference, NCRM NICHE with Fujio Cup Quiz (FCQ), E-poster and Edogawa NICH – Times of India
stemadminStem Cell ResearchNo comments

The XVI edition of NCRM NICHE (www.ncrmniche.org), a one of its kind stem cells and regenerative medicine meet will be conducted on the 17th of October, 2021 in a hybrid mode from Japan with virtual telecast this year. The NCRM NICHE has been conducted annually for the past fifteen years having witnessed participation from scholars and experts from 180 institutes across 20 different countries, which has unique active knowledge gaining (AKG) events and Passive Knowledge gaining (PKG) events, incorporating the Edogawa NICHE Prize 2021 (www.edogawanicheprize.org). AKG event refers to any knowledge gaining activity in which the participant plays an active role.

Read more

Theme: Illdy.